BioSpace News Archive

The demand within the global spatial genomics and transcriptomics market is expanding at a stellar pace in the years to follow.

Albany NY, United States: Neglected tropical diseases are a wide variety of tropical infections that are common in countries with low or minimum income.

Lipidor AB announces that half of the patients have now been enrolled in the Phase III study of AKP02 skin spray for mild to moderate psoriasis, with the last patient expected to begin treatment in June 2022.

LumiraDx Limited, a next-generation point of care diagnostics company, announced that its rapid COVID-19 antigen assay, LumiraDx SARS-CoV-2 Ag Test has successfully received the Emergency Use Listing by the World Health Organization in their latest response effort to combat COVID-19.

Immuneering Corporation announced that management will present the company’s pipeline, platform, and business strategy at the Jefferies Healthcare Conference and the H.C. Wainwright Global Investment Conference, details of which are set forth below.

Grant From Research to Prevent Blindness and Castle Biosciences Supports Medical Student Research in Ocular Cancer.

Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, presented data demonstrating that the clinical stage selective IRAK4 degrader KT-474 degrades IRAK4 and inhibits cytokine production in different immune and skin cell types at the Society of Investigative Dermatology (SID) Annual Meeting 2022.

Braxia Scientific Corp. a medical research company with clinics providing and advancing innovative ketamine and other innovative treatments for people living with depression and related mental health disorders.

Sirnaomics Ltd. announced that the Company’s Executive Director and Chief Medical Officer, Dr. Michael Molyneaux, will present clinical study results of its leading product candidate STP705 for the treatment of non-melanoma skin cancers, and the Company’s clinical development strategy based on its strong presence in both the U.S. and China, at the 2022 Pre-ASCO China Summit.

Albany NY, United States: The benefits attached to concierge medicine as compared to traditional healthcare are estimated to serve as a prime growth factor for the concierge medicine market during the forecast period of 2021-2031.